Recent Progress of Adenosine Receptor Modulators in the Development of Anticancer Chemotherapeutic Agents.

Marwein, Sarapynbiang; Mishra, Bijayashree; De, Utpal C; Acharya, Pratap C

Marwein, Sarapynbiang; Mishra, Bijayashree; De, Utpal C; Acharya, Pratap C.

Afiliación

Marwein S; Department of Pharmacy, Tripura University (A Central University), Suryamaninagar-799022, Tripura (W), India.
Mishra B; Department of Chemistry, Tripura University (A Central University), Suryamaninagar-799022, Tripura (W), India.
De UC; Department of Chemistry, Tripura University (A Central University), Suryamaninagar-799022, Tripura (W), India.
Acharya PC; Department of Pharmacy, Tripura University (A Central University), Suryamaninagar-799022, Tripura (W), India.

Curr Pharm Des ; 25(26): 2842-2858, 2019.

Article en En | MEDLINE | ID: mdl-31333105

Asunto(s)

Antineoplásicos/farmacología; Neoplasias/tratamiento farmacológico; Agonistas del Receptor Purinérgico P1/farmacología; Antagonistas de Receptores Purinérgicos P1/farmacología; Humanos; Calidad de Vida; Receptores Purinérgicos P1

Palabras clave

A2AAR antagonists; A3AR antagonist; A3AR agonists; Adenosine receptors; angiogenesis; anticancer agents; hypoxia; immunomodulation; pro-tumoral and anti-tumoral effects.

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Agonistas del Receptor Purinérgico P1 / Antagonistas de Receptores Purinérgicos P1 / Neoplasias / Antineoplásicos Tipo de estudio: Prognostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Curr Pharm Des Asunto de la revista: FARMACIA Año: 2019 Tipo del documento: Article País de afiliación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google